Systematic assessment and improvement of medical data quality

被引:10
作者
Jacke, C. O. [1 ]
Kalder, M. [2 ]
Koller, M. [3 ]
Wagner, U. [2 ]
Albert, U. S. [2 ]
机构
[1] Heidelberg Univ, Zent Inat Seel Gesundheit, Med Fak Mannheim, AG Versorgungsforsch, D-68159 Mannheim, Germany
[2] Univ Klinikum Marburg & Giessen, Standort Marburg, Germany
[3] Univ Klinikum Regensburg, Zentrum Klin Studien, Regensburg, Germany
关键词
Data quality; Cohort studies; Guidelines; Source data verification; Data quality indicators (DQI); BREAST-CANCER THERAPY; GERMANY; CENTERS; CARE;
D O I
10.1007/s00103-012-1536-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Public health research depends on empirical information that is based on data of high quality. The aim of this study was to apply the current guidelines developed by the Technology and Methodology Platform for Networked Medical Research (TMF) for the independent assessment and enhancement of data quality. A clinical register of female breast cancer patients from two periods (N = 389 of 1996-1997 and N = 488 of 2003-2004) was used. To check the plausibility, organization, and correctness of the data quality levels, data quality indicators (DQI) were chosen, operationalized, and the variance ratios of normative-analytic-defined thresholds were calculated. Significant deviations led to data improvement, which included the commonly known source data verification (SDV). A summary data quality score was calculated before and after application of the guidelines. Eleven out of 24 DQIs were tested. Data quality systematically increased from 51.6 to 67.7%. The guidelines facilitate a systematic assessment and improvement of data quality with a reasonable use of resources. This target-oriented procedure allows for a high transparency of the available data quality, which is essential for health research.
引用
收藏
页码:1495 / 1503
页数:9
相关论文
共 41 条
[31]  
Kreienberg R., 2008, Interdisziplinare S3-Leitlinie fur die Diagnostik, Therapie und Nachsorge des Mammakarzinoms
[32]  
Lash TL., 2009, Applying quantitative bias analysis to epidemiologic data
[33]   Cancer Survival Analysis in Germany - Heading Towards Representative and Comparable Findings [J].
Nennecke, A. ;
Brenner, H. ;
Eberle, A. ;
Geiss, K. ;
Holleczek, B. ;
Kieschke, J. ;
Kraywinkel, K. .
GESUNDHEITSWESEN, 2010, 72 (10) :692-699
[34]   Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness [J].
Parkin, D. Max ;
Bray, Freddie .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) :756-764
[35]  
Rosner B, 2006, Fundamentals of biostatistics, V6th
[36]  
Rothman KJ, 2008, Modern Epidemiology, 3rd Edition
[37]  
Schnell R., 2005, METHODEN EMPIRISCHEN
[38]   A modell for breast cancer networking: 'Brustzentrum regio' [J].
Wagner, Uwe ;
Albert, Ute-Susann .
BREAST CARE, 2006, 1 (03) :198-199
[39]   Understanding what works - and why - in quality improvement: the need for theory-driven evaluation [J].
Walshe, Kieran .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2007, 19 (02) :57-59
[40]   Pseudoinnovation: the development and spread of healthcare quality improvement methodologies [J].
Walshe, Kieran .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2009, 21 (03) :153-159